By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IDBS said today it will be providing its Oncology Research Information System translational medicine platform for the Integrated Cancer Centre at King's Health Partners.

The deal, the UK data management and analytics solutions firm said, is the first step in a five-year relationship that may eventually include all disease areas including cancer disorders and cardiovascular diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.